arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

BioCorRx Inc.

BICX
Price unavailable
Industrials ·Services-Specialty Outpatient Facilities, NEC ·USServices-Specialty Outpatient Facilities, NEC
69 Visible periods
30 Metrics
Peer-ranked Benchmarks
Price Chart
41
Health
Weak
Neutral
auto_awesome

Analytical Summary

BioCorRx Inc. shows mixed fundamentals. Consider comparing against peers in the Industrials sector before making investment decisions.

Market Cap
Dividend Yield
Revenue Growth 59.0%
Op. Margin -445.6%
ROIC 8.3%
FCF / Share None
Trailing P/E
Price / Book
FCF Yield
Debt / Equity
info Valuation on last close.

69-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$214.54K
↑ +59.0%
Net Income Profit after all expenses
$-831.23K
↑ +1.2%
Operating Margin Operating profit as % of sales
-445.6%
↓ -45.5%
FCF / Share Free cash flow per share
$-0.01
↑ +53.7%
trending_up

Bullish Indicators

  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability
0
Returns
93
Financial Health
24
Cash Quality
47

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 17 years · 69 quarters